Go Pro
→ Forget SpaceX, Elon Is Now Powering the Next Hot IPO (From Brownstone Research) (Ad)tc pixel Free IPAR Stock Alerts

Interparfums (IPAR) Financials

Interparfums logo
$111.78 -2.85 (-2.49%)
As of 08/17/2026 04:00 PM Eastern
Compare
Annual Income Statements for Interparfums

Annual Income Statements for Interparfums

This table shows Interparfums' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 29 30 33 42 54 60 38 87 121 153 164
Consolidated Net Income / (Loss)		 37 39 43 55 70 76 50 110 151 188 203
Net Income / (Loss) Continuing Operations		 37 39 43 55 70 76 50 110 151 188 203
Total Pre-Tax Income 		57 60 67 78 96 105 69 151 194 250 268
Total Operating Income		 53 61 67 79 95 105 70 148 194 251 275
Total Gross Profit		 287 289 326 376 428 446 331 557 694 839 927
Total Revenue		 499 469 521 591 676 714 539 880 1,087 1,318 1,452
Operating Revenue		 499 469 521 591 676 714 539 880 1,087 1,318 1,452
Total Cost of Revenue		 212 179 195 215 248 268 208 323 392 479 525
Operating Cost of Revenue		 212 179 195 215 248 268 208 323 392 479 525
Total Operating Expenses		 234 228 260 298 333 341 261 409 500 588 653
Selling, General & Admin Expense		 234 228 259 296 333 341 261 406 492 588 649
Impairment Charge		 0.00 0.00 5.66 2.12 - 0.00 0.00 2.39 7.75 0.00 4.01
Total Other Income / (Expense), net		 3.31 -0.71 0.40 -0.56 1.13 0.42 -0.73 2.92 -0.08 -1.79 -6.41
Interest Expense		 1.48 2.83 2.34 1.99 2.58 2.15 1.97 2.83 3.60 11 7.83
Interest & Investment Income		 3.89 3.00 3.33 2.98 3.96 3.69 2.87 3.40 5.49 11 2.22
Other Income / (Expense), net		 0.90 -0.88 -0.60 -1.55 -0.25 -1.13 -1.63 2.34 -1.97 -1.27 -0.80
Income Tax Expense		 19 22 24 23 26 29 19 41 43 62 65
Net Income / (Loss) Attributable to Noncontrolling Interest		 7.91 8.53 9.92 14 16 16 12 23 30 35 39
Basic Earnings per Share		 $0.95 $0.98 $1.07 $1.33 $1.72 $1.92 $1.21 $2.76 $3.80 $4.77 $5.13
Weighted Average Basic Shares Outstanding		 30.93M 31.00M 31.07M 31.17M 31.31M 31.45M 31.54M 31.68M 31.86M 31.99M 32.04M
Diluted Earnings per Share		 $0.95 $0.98 $1.07 $1.33 $1.71 $1.90 $1.21 $2.75 $3.78 $4.75 $5.12
Weighted Average Diluted Shares Outstanding		 31.06M 31.10M 31.18M 31.31M 31.52M 31.69M 31.65M 31.84M 31.99M 32.14M 32.12M
Weighted Average Basic & Diluted Shares Outstanding		 31M 31.10M 31.20M 31.30M 31.44M 31.53M 31.64M 31.84M 32.11M 32.02M 32.12M
Cash Dividends to Common per Share		 $0.48 $0.52 $0.62 $0.72 $0.91 $1.16 $0.33 $1.00 $2.00 $2.50 $3.00

Quarterly Income Statements for Interparfums

This table shows Interparfums' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 53 10 41 37 62 24 42 32 66 43 30
Consolidated Net Income / (Loss)		 66 8.23 53 47 77 27 55 41 83 57 37
Net Income / (Loss) Continuing Operations		 66 8.23 53 47 77 27 55 41 83 57 37
Total Pre-Tax Income 		87 15 70 61 100 37 73 54 108 75 48
Total Operating Income		 87 19 68 65 106 36 75 59 109 74 49
Total Gross Profit		 235 213 202 221 271 233 216 221 273 225 224
Total Revenue		 368 329 324 342 425 362 339 334 430 345 341
Operating Revenue		 368 329 324 342 425 362 339 334 430 345 341
Total Cost of Revenue		 133 116 122 121 153 128 123 113 157 120 118
Operating Cost of Revenue		 133 116 122 121 153 128 123 113 157 120 118
Total Operating Expenses		 148 194 134 156 165 197 141 162 164 151 175
Selling, General & Admin Expense		 148 194 134 156 165 193 141 162 164 151 175
Total Other Income / (Expense), net		 -0.59 -3.96 2.08 -3.58 -5.59 0.68 -1.67 -5.05 -1.00 1.07 -0.70
Interest Expense		 2.40 4.22 1.81 1.94 1.98 2.10 1.55 1.79 2.31 1.43 1.46
Interest & Investment Income		 1.06 2.31 3.02 -1.08 -0.25 0.53 0.58 -1.93 2.55 2.32 0.69
Other Income / (Expense), net		 0.75 -2.05 0.87 -0.56 -3.36 2.25 -0.70 -1.34 -1.24 0.19 0.07
Income Tax Expense		 20 6.69 17 15 24 9.98 18 13 24 19 11
Net Income / (Loss) Attributable to Noncontrolling Interest		 13 -2.19 12 9.78 15 2.47 13 9.21 17 13 6.40
Basic Earnings per Share		 $1.66 $0.33 $1.28 $1.15 $1.94 $0.76 $1.32 $1.00 $2.05 $1.35 $0.95
Weighted Average Basic Shares Outstanding		 31.98M 31.99M 32.04M 32.02M 32.03M 32.04M 32.12M 32.11M 32.11M 32.03M 32.03M
Diluted Earnings per Share		 $1.66 $0.32 $1.27 $1.14 $1.93 $0.78 $1.32 $0.99 $2.05 $1.35 $0.95
Weighted Average Diluted Shares Outstanding		 32.12M 32.14M 32.27M 32.27M 32.27M 32.12M 32.17M 32.15M 32.15M 32.03M 32.03M
Weighted Average Basic & Diluted Shares Outstanding		 31.98M 32.02M 32.02M 32.02M 32.03M 32.12M 32.12M 32.12M 32.06M 32.03M 32.03M
Cash Dividends to Common per Share		 $0.63 $0.63 $0.75 $0.75 $0.75 $0.75 $0.80 $0.80 $0.80 $0.80 $0.80

Annual Cash Flow Statements for Interparfums

This table details how cash moves in and out of Interparfums' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -36 87 -15 47 -15 -60 36 -1.29 -64 -16 37
Net Cash From Operating Activities		 37 50 55 36 63 76 65 120 73 106 188
Net Cash From Continuing Operating Activities		 37 50 55 106 63 76 65 120 73 106 188
Net Income / (Loss) Continuing Operations		 37 39 43 55 70 76 50 110 151 188 203
Consolidated Net Income / (Loss)		 37 39 43 55 70 76 50 110 151 188 203
Depreciation Expense		 10 9.08 15 12 11 8.73 9.07 13 23 17 28
Amortization Expense		 - - - - - - - - 4.98 5.45 6.27
Non-Cash Adjustments To Reconcile Net Income		 0.60 0.97 -3.11 3.03 3.65 11 13 11 2.17 0.47 2.54
Changes in Operating Assets and Liabilities, net		 -11 1.07 -0.92 -34 -21 -19 -6.69 -14 -108 -105 -53
Net Cash From Investing Activities		 -37 -35 -20 37 -14 -65 -22 -188 -91 7.26 -45
Net Cash From Continuing Investing Activities		 -37 -35 -20 37 -14 -65 -22 -188 -91 7.26 -45
Purchase of Property, Plant & Equipment		 -3.30 -4.16 -4.78 -3.02 -3.96 -5.43 -11 -141 -34 -6.47 -4.74
Acquisitions		 -0.92 -120 -0.97 -1.05 -8.51 -6.07 -15 -1.55 -57 -47 -18
Purchase of Investments		 -246 -62 -57 -32 -10 -98 -7.58 -56 -1.04 -221 -206
Sale and/or Maturity of Investments		 213 152 43 67 8.86 45 12 11 0.90 282 184
Net Cash From Financing Activities		 -23 82 -45 -48 -56 -68 -19 78 -46 -133 -101
Net Cash From Continuing Financing Activities		 -23 82 -45 -48 -56 -68 -19 78 -46 -133 -101
Repayment of Debt		 -5.77 -12 -22 -22 -23 -22 -14 -43 -20 -29 -35
Repurchase of Common Equity		 -0.09 -0.03 -0.08 - - - - 0.00 0.00 -15 0.00
Payment of Dividends		 -20 -20 -23 -27 -36 -50 -21 -42 -84 -101 -121
Issuance of Debt		 0.00 111 - - 0.00 0.00 13 157 52 4.33 48
Other Financing Activities, net		 2.65 2.24 0.20 1.96 3.41 4.46 2.77 5.39 6.00 8.03 7.05
Effect of Exchange Rate Changes		 -12 -10 -4.64 21 -8.73 -3.35 12 -11 -0.49 3.93 -5.07
Cash Interest Paid		 1.51 2.40 2.24 1.81 1.75 1.76 1.11 2.47 2.99 5.82 7.50
Cash Income Taxes Paid		 104 20 28 24 25 26 22 40 38 61 63

Quarterly Cash Flow Statements for Interparfums

This table details how cash moves in and out of Interparfums' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 5.45 8.70 -67 18 39 47 -29 55 -41 -78 90
Net Cash From Operating Activities		 18 81 -52 26 76 138 -7.36 12 64 0.09 46
Net Cash From Continuing Operating Activities		 18 81 -52 26 76 138 -7.36 12 64 0.09 46
Net Income / (Loss) Continuing Operations		 66 8.23 53 47 77 27 55 41 83 57 37
Consolidated Net Income / (Loss)		 66 8.23 53 47 77 27 55 41 83 57 37
Depreciation Expense		 4.41 4.55 6.02 6.00 6.18 10 5.93 6.36 6.55 5.80 5.83
Amortization Expense		 - - 1.49 - - - 1.75 2.22 0.84 1.61 1.44
Non-Cash Adjustments To Reconcile Net Income		 2.18 -4.89 -1.02 2.87 -3.08 0.79 0.44 0.20 1.71 0.97 -0.02
Changes in Operating Assets and Liabilities, net		 -55 68 -112 -30 -3.80 94 -71 -38 -29 -65 1.45
Net Cash From Investing Activities		 2.95 -33 14 37 -39 -56 14 11 -26 -27 115
Net Cash From Continuing Investing Activities		 2.95 -33 14 37 -39 -56 14 11 -26 -27 115
Purchase of Property, Plant & Equipment		 -1.37 -1.89 -1.06 -1.06 -0.77 -1.85 -1.44 -15 -6.24 -1.36 -1.03
Acquisitions		 -1.84 -45 -0.31 -0.27 -0.28 -17 -22 -1.36 0.97 -1.78 -0.96
Purchase of Investments		 -48 -76 -60 -21 -66 -59 -32 -16 -46 -105 -11
Sale and/or Maturity of Investments		 55 89 75 59 28 22 69 43 25 82 128
Net Cash From Financing Activities		 -13 -43 -28 -44 0.08 -29 -38 26 -78 -50 -70
Net Cash From Continuing Financing Activities		 -13 -43 -28 -44 0.08 -29 -38 26 -78 -50 -70
Repayment of Debt		 -6.57 -6.27 -9.43 -6.53 -8.83 -9.91 -12 -11 -13 -15 -20
Payment of Dividends		 -20 -21 -24 -48 -25 -24 -26 -53 -26 -27 -54
Issuance of Debt		 13 -14 4.00 10 34 -0.21 -1.05 91 -34 -4.68 4.68
Effect of Exchange Rate Changes		 -1.97 3.19 -1.32 -0.21 2.16 -5.71 3.47 6.42 -0.60 -1.32 -0.92
Cash Interest Paid		 1.47 1.16 1.13 3.14 2.31 0.92 1.40 1.63 1.96 1.35 1.20
Cash Income Taxes Paid		 15 16 10 22 16 15 9.48 28 19 12 13

Annual Balance Sheets for Interparfums

This table presents Interparfums' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 688 682 778 798 829 890 1,145 1,309 1,369 1,411 1,585
Total Current Assets		 469 472 549 572 573 601 710 788 839 915 1,027
Cash & Equivalents		 177 162 208 193 133 170 160 105 88 125 158
Short-Term Investments		 83 94 70 68 120 127 160 151 94 109 137
Accounts Receivable		 98 112 123 135 135 126 170 226 254 281 330
Inventories, net		 98 97 137 162 168 159 199 290 372 372 351
Current Deferred & Refundable Income Taxes		 7.28 0.63 3.47 0.81 0.17 2.81 0.21 0.16 0.69 0.31 11
Other Current Assets		 5.81 6.24 7.36 13 17 17 21 16 29 27 40
Plant, Property, & Equipment, net		 9.33 10 10 9.84 11 20 149 167 169 154 185
Total Noncurrent Assets		 210 200 218 216 244 270 286 354 361 343 373
Intangible Assets		 201 184 200 204 202 214 214 291 296 282 325
Noncurrent Deferred & Refundable Income Taxes		 - 8.09 9.66 5.76 8.00 8.04 7.94 11 15 17 4.23
Other Noncurrent Operating Assets		 8.23 8.25 8.01 6.30 34 48 64 52 50 43 44
Total Liabilities & Shareholders' Equity		 688 682 778 798 829 890 1,145 1,309 1,369 1,411 1,585
Total Liabilities		 211 199 207 212 220 188 407 520 477 469 481
Total Current Liabilities		 131 142 167 189 184 156 245 345 325 332 344
Short-Term Debt		 22 21 24 23 12 15 16 29 34 50 64
Accounts Payable		 51 50 53 58 54 36 82 88 97 91 77
Accrued Expenses		 47 63 82 95 96 96 137 214 179 173 190
Current Deferred & Payable Income Tax Liabilities		 7.36 3.33 1.72 4.40 5.87 5.30 4.33 8.72 8.50 13 6.67
Other Current Liabilities		 - - - 0.00 5.36 5.13 6.01 5.30 5.95 6.09 6.33
Total Noncurrent Liabilities		 80 57 40 23 35 31 162 176 152 136 137
Long-Term Debt		 76 53 36 23 11 10 133 151 128 116 121
Noncurrent Deferred & Payable Income Tax Liabilities		 3.75 3.45 3.82 - - - - - - - 0.00
Other Noncurrent Operating Liabilities		 - - - - 25 - 29 - 25 - 16
Total Equity & Noncontrolling Interests		 476 484 571 586 609 702 738 788 892 943 1,104
Total Preferred & Common Equity		 366 370 433 448 468 536 572 617 699 745 881
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 366 370 433 448 468 536 572 617 699 745 881
Common Stock		 62 63 66 70 71 76 87 90 99 107 128
Retained Earnings		 388 403 423 449 475 504 561 620 694 763 829
Treasury Stock		 -37 -37 -37 -37 -37 -37 -37 -37 -53 -53 -67
Accumulated Other Comprehensive Income / (Loss)		 -48 -58 -18 -34 -40 -6.00 -38 -56 -40 -72 -9.03
Noncontrolling Interest		 111 113 137 138 141 167 166 171 193 198 223

Quarterly Balance Sheets for Interparfums

This table presents Interparfums' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 1,380 1,352 1,394 1,349 1,364 1,481 1,441 1,562 1,565 1,543 1,490
Total Current Assets		 852 823 877 833 857 956 911 987 991 998 951
Cash & Equivalents		 149 74 80 21 39 78 97 151 110 80 170
Short-Term Investments		 89 112 104 76 38 79 75 54 77 157 42
Accounts Receivable		 270 251 302 299 304 359 309 304 374 339 311
Inventories, net		 324 360 364 400 434 413 396 425 388 370 376
Current Deferred & Refundable Income Taxes		 0.07 0.39 0.50 2.49 19 0.53 0.06 2.02 0.00 7.81 3.76
Other Current Assets		 20 25 27 34 24 27 35 50 41 45 49
Plant, Property, & Equipment, net		 169 168 163 164 161 166 159 185 186 179 176
Total Noncurrent Assets		 360 360 355 352 346 358 371 389 388 366 363
Intangible Assets		 294 292 287 288 282 291 312 333 328 317 312
Noncurrent Deferred & Refundable Income Taxes		 13 14 16 16 17 20 16 13 15 5.31 9.85
Other Noncurrent Operating Assets		 53 53 52 49 46 47 42 43 44 43 41
Total Liabilities & Shareholders' Equity		 1,380 1,352 1,394 1,349 1,364 1,481 1,441 1,562 1,565 1,543 1,490
Total Liabilities		 531 505 518 441 463 495 433 505 460 430 399
Total Current Liabilities		 362 342 363 302 332 340 306 333 303 306 287
Short-Term Debt		 47 34 46 37 47 53 51 101 66 55 49
Accounts Payable		 93 91 87 106 109 97 99 93 67 85 83
Accrued Expenses		 190 194 200 136 145 166 129 127 153 151 146
Current Deferred & Payable Income Tax Liabilities		 26 17 24 17 26 17 22 5.57 11 8.78 2.99
Other Current Liabilities		 5.31 5.24 5.69 5.93 5.95 6.19 6.15 6.25 6.19 6.21 6.15
Total Noncurrent Liabilities		 168 163 154 139 130 156 127 172 157 124 112
Long-Term Debt		 145 139 129 116 108 135 107 153 140 107 97
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - - - - 2.50 2.48
Other Noncurrent Operating Liabilities		 - 24 25 - - - - - 17 - 13
Total Equity & Noncontrolling Interests		 850 847 877 908 901 985 1,008 1,057 1,104 1,113 1,091
Total Preferred & Common Equity		 658 668 690 708 717 778 789 839 871 882 870
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 658 668 690 708 717 778 789 839 871 882 870
Common Stock		 95 96 96 100 101 101 108 109 109 128 128
Retained Earnings		 654 670 703 711 724 763 780 787 827 847 839
Treasury Stock		 -43 -49 -49 -53 -53 -53 -53 -55 -60 -71 -71
Accumulated Other Comprehensive Income / (Loss)		 -48 -49 -60 -50 -55 -33 -47 -1.60 -4.78 -22 -25
Noncontrolling Interest		 191 179 187 200 184 207 219 217 234 231 220

Annual Metrics And Ratios for Interparfums

This table displays calculated financial ratios and metrics derived from Interparfums' official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
DEI Shares Outstanding		 - - - - - - - - 31,875,625.00 63,961,610.00 32,030,280.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 31,875,625.00 63,961,610.00 32,030,280.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - 3.79 2.39 5.13
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -11.41% -6.15% 11.21% 13.47% 14.26% 5.62% -24.46% 63.17% 23.55% 21.26% 10.22%
EBITDA Growth		 -27.31% 7.65% 17.32% 9.29% 18.57% 6.46% -30.99% 110.44% 34.81% 24.13% 13.09%
EBIT Growth		 -30.01% 11.09% 9.54% 16.63% 22.58% 9.65% -33.92% 119.77% 27.89% 30.04% 9.55%
NOPAT Growth		 -29.35% 12.12% 9.05% 29.44% 23.80% 9.98% -33.35% 113.61% 40.09% 25.16% 10.13%
Net Income Growth		 -26.73% 4.35% 10.98% 27.76% 26.17% 9.12% -34.31% 120.19% 37.27% 24.32% 8.34%
EPS Growth		 -25.20% 3.16% 9.18% 24.30% 28.57% 11.11% -36.32% 127.27% 37.45% 25.66% 7.79%
Operating Cash Flow Growth		 -25.57% 36.79% 8.95% -34.22% 75.65% 21.27% -14.99% 84.00% -38.93% 44.83% 77.40%
Free Cash Flow Firm Growth		 45.23% -213.43% 195.44% -93.43% 1,262.61% 34.44% -118.79% -196.24% -146.32% 398.49% 238.73%
Invested Capital Growth		 -6.47% 43.50% -3.68% 16.93% 5.53% 2.61% 16.15% 31.96% 29.86% 18.23% 2.61%
Revenue Q/Q Growth		 4.09% -1.43% 3.26% 2.56% 4.28% 0.08% 1.17% 3.13% 10.14% 1.38% 2.31%
EBITDA Q/Q Growth		 29.94% 1.10% 7.83% -4.60% 18.68% 1.37% 19.51% -17.15% 23.77% -1.33% 12.09%
EBIT Q/Q Growth		 38.42% 1.41% 0.07% -0.78% 6.27% 1.84% 22.87% -19.69% 19.27% -0.82% 8.48%
NOPAT Q/Q Growth		 41.01% -4.44% 7.33% 3.21% 5.53% -0.80% 23.78% -19.55% 20.94% -3.75% 7.78%
Net Income Q/Q Growth		 37.39% -5.47% 7.67% 2.18% 5.12% -0.44% 21.87% -17.45% 17.41% -4.43% 9.98%
EPS Q/Q Growth		 31.94% -3.92% 5.94% 0.76% 7.55% 0.00% 22.22% 0.00% 17.03% -4.04% 9.87%
Operating Cash Flow Q/Q Growth		 153.15% 34.22% 9.11% -29.64% 30.61% 4.02% 31.05% -35.85% 619.52% 0.27% 43.04%
Free Cash Flow Firm Q/Q Growth		 145.14% 21.87% 30.98% -89.53% 55.97% 33.79% -144.09% -211.02% -583.06% 107.35% 655.98%
Invested Capital Q/Q Growth		 -17.65% -17.04% -19.73% -10.70% -13.07% -16.03% -5.07% 3.35% 5.50% 0.31% -13.81%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 57.49% 61.78% 62.65% 63.64% 63.29% 62.50% 61.36% 63.32% 63.90% 63.68% 63.85%
EBITDA Margin		 12.91% 14.81% 15.63% 15.05% 15.62% 15.74% 14.38% 18.55% 20.23% 20.71% 21.25%
Operating Margin		 10.70% 13.06% 12.80% 13.30% 14.02% 14.68% 13.00% 16.83% 17.88% 19.08% 18.92%
EBIT Margin		 10.88% 12.88% 12.68% 13.04% 13.99% 14.52% 12.70% 17.11% 17.70% 18.98% 18.87%
Profit (Net Income) Margin		 7.48% 8.32% 8.30% 9.35% 10.32% 10.66% 9.27% 12.51% 13.90% 14.25% 14.01%
Tax Burden Percent		 65.85% 64.42% 64.48% 70.78% 72.73% 72.35% 72.05% 72.86% 77.77% 75.23% 75.80%
Interest Burden Percent		 104.44% 100.28% 101.50% 101.29% 101.46% 101.49% 101.31% 100.38% 100.98% 99.79% 97.95%
Effective Tax Rate		 34.15% 35.58% 35.52% 29.22% 27.27% 27.65% 27.95% 27.14% 22.23% 24.77% 24.20%
Return on Invested Capital (ROIC)		 15.28% 14.56% 13.72% 16.69% 18.65% 19.71% 12.00% 20.57% 23.17% 23.52% 23.60%
ROIC Less NNEP Spread (ROIC-NNEP)		 14.52% 14.77% 13.57% 16.89% 18.25% 19.57% 12.23% 19.46% 23.23% 27.26% 37.57%
Return on Net Nonoperating Assets (RNNOA)		 -8.06% -6.56% -4.71% -6.20% -6.59% -6.98% -4.38% -5.29% -3.38% -1.17% -1.42%
Return on Equity (ROE)		 7.22% 7.99% 9.01% 10.48% 12.06% 12.73% 7.62% 15.27% 19.79% 22.35% 22.17%
Cash Return on Invested Capital (CROIC)		 21.97% -21.17% 17.46% 1.08% 13.26% 17.14% -2.94% -6.99% -2.81% 6.81% 21.03%
Operating Return on Assets (OROA)		 8.56% 9.34% 9.65% 10.56% 11.99% 12.74% 7.96% 14.78% 15.68% 18.68% 19.71%
Return on Assets (ROA)		 5.89% 6.03% 6.31% 7.57% 8.85% 9.35% 5.81% 10.81% 12.31% 14.02% 14.63%
Return on Common Equity (ROCE)		 5.51% 6.13% 6.91% 7.99% 9.19% 9.76% 5.83% 11.74% 15.41% 17.51% 17.45%
Return on Equity Simple (ROE_SIMPLE)		 9.77% 10.66% 11.68% 12.75% 15.58% 16.25% 9.33% 19.24% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 35 39 43 56 69 76 50 108 151 189 208
NOPAT Margin		 7.04% 8.41% 8.25% 9.41% 10.20% 10.62% 9.37% 12.26% 13.91% 14.35% 14.34%
Net Nonoperating Expense Percent (NNEP)		 0.76% -0.21% 0.15% -0.20% 0.39% 0.14% -0.23% 1.10% -0.06% -3.74% -13.97%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 15.22% 17.94% 18.45%
Cost of Revenue to Revenue		 42.51% 38.22% 37.35% 36.36% 36.71% 37.50% 38.64% 36.68% 36.10% 36.32% 36.15%
SG&A Expenses to Revenue		 46.80% 48.72% 49.66% 49.99% 49.27% 47.82% 48.36% 46.21% 45.31% 44.60% 44.66%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 46.80% 48.72% 49.86% 50.34% 49.27% 47.82% 48.36% 46.49% 46.02% 44.60% 44.93%
Earnings before Interest and Taxes (EBIT)		 54 60 66 77 94 104 68 150 192 250 274
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 64 69 81 89 106 112 78 163 220 273 309
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.00 1.85 2.57 2.98 4.45 4.83 3.53 5.95 4.60 6.19 5.44
Price to Tangible Book Value (P/TBV)		 2.70 4.12 5.10 5.55 8.19 8.49 5.88 9.51 8.71 10.74 8.77
Price to Revenue (P/Rev)		 1.53 1.44 1.83 2.18 2.95 3.17 3.51 3.87 2.61 3.28 2.79
Price to Earnings (P/E)		 25.97 22.23 28.55 31.04 37.05 37.49 49.46 38.93 23.47 28.35 24.67
Dividend Yield		 1.95% 2.39% 2.03% 1.75% 1.43% 1.62% 2.03% 0.94% 2.25% 1.85% 2.37%
Earnings Yield		 3.85% 4.50% 3.50% 3.22% 2.70% 2.67% 2.02% 2.57% 4.26% 3.53% 4.05%
Enterprise Value to Invested Capital (EV/IC)		 2.70 1.96 2.87 3.37 5.05 5.57 4.00 5.74 4.01 5.17 4.70
Enterprise Value to Revenue (EV/Rev)		 1.20 1.34 1.70 2.05 2.84 3.04 3.35 3.90 2.72 3.42 2.90
Enterprise Value to EBITDA (EV/EBITDA)		 9.32 9.02 10.85 13.61 18.16 19.32 23.31 21.01 13.46 16.49 13.62
Enterprise Value to EBIT (EV/EBIT)		 11.07 10.38 13.37 15.71 20.28 20.95 26.39 22.79 15.38 17.99 15.35
Enterprise Value to NOPAT (EV/NOPAT)		 17.10 15.88 20.55 21.76 27.82 28.64 35.78 31.78 19.58 23.80 20.19
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.42 12.50 16.19 33.73 30.40 28.38 27.80 28.67 40.51 42.55 22.41
Enterprise Value to Free Cash Flow (EV/FCFF)		 11.89 0.00 16.14 336.71 39.11 32.94 0.00 0.00 0.00 82.14 22.66
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.21 0.15 0.11 0.08 0.04 0.07 0.24 0.26 0.18 0.20
Long-Term Debt to Equity		 0.00 0.16 0.11 0.06 0.04 0.02 0.04 0.22 0.22 0.14 0.14
Financial Leverage		 -0.55 -0.44 -0.35 -0.37 -0.36 -0.36 -0.36 -0.27 -0.15 -0.04 -0.04
Leverage Ratio		 1.23 1.33 1.43 1.39 1.36 1.36 1.31 1.41 1.61 1.59 1.52
Compound Leverage Factor		 1.28 1.33 1.45 1.40 1.38 1.38 1.33 1.42 1.62 1.59 1.48
Debt to Total Capital		 0.06% 17.15% 13.36% 9.60% 7.29% 3.65% 6.15% 19.43% 20.59% 15.36% 16.49%
Short-Term Debt to Total Capital		 0.06% 3.85% 3.85% 3.86% 3.66% 1.95% 1.95% 1.74% 2.88% 3.23% 4.42%
Long-Term Debt to Total Capital		 0.00% 13.29% 9.51% 5.74% 3.63% 1.70% 4.21% 17.69% 17.72% 12.13% 12.07%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 23.38% 19.27% 20.29% 21.76% 21.86% 22.31% 22.26% 18.16% 17.27% 18.29% 17.52%
Common Equity to Total Capital		 76.56% 63.58% 66.35% 68.65% 70.85% 74.04% 71.59% 62.41% 62.14% 66.35% 65.99%
Debt to EBITDA		 0.00 1.42 0.92 0.68 0.44 0.21 0.59 1.09 0.93 0.59 0.60
Net Debt to EBITDA		 -4.34 -2.32 -2.23 -2.45 -2.04 -2.05 -3.23 -0.87 -0.23 -0.08 -0.16
Long-Term Debt to EBITDA		 0.00 1.10 0.65 0.41 0.22 0.10 0.41 0.99 0.80 0.47 0.44
Debt to NOPAT		 0.01 2.50 1.73 1.09 0.67 0.30 0.91 1.65 1.35 0.86 0.89
Net Debt to NOPAT		 -7.96 -4.09 -4.22 -3.91 -3.12 -3.04 -4.96 -1.31 -0.34 -0.11 -0.23
Long-Term Debt to NOPAT		 0.00 1.94 1.23 0.65 0.33 0.14 0.62 1.50 1.16 0.68 0.65
Altman Z-Score		 7.09 4.27 5.36 6.18 8.24 8.80 8.29 7.39 5.66 8.17 8.11
Noncontrolling Interest Sharing Ratio		 23.67% 23.33% 23.34% 23.77% 23.82% 23.36% 23.46% 23.11% 22.13% 21.67% 21.29%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.70 3.58 3.32 3.29 3.02 3.11 3.85 2.90 2.29 2.58 2.75
Quick Ratio		 3.59 2.73 2.59 2.40 2.10 2.10 2.70 2.00 1.40 1.35 1.55
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 51 -57 55 3.60 49 66 -12 -37 -18 55 186
Operating Cash Flow to CapEx		 1,108.81% 1,204.52% 1,142.22% 1,187.26% 1,593.55% 1,408.73% 590.26% 84.65% 216.35% 1,636.10% 3,958.69%
Free Cash Flow to Firm to Interest Expense		 34.20 -20.29 23.39 1.81 19.01 30.70 -6.28 -12.98 -5.10 4.87 23.72
Operating Cash Flow to Interest Expense		 24.77 17.72 23.32 18.02 24.45 35.63 32.99 42.33 20.29 9.40 23.98
Operating Cash Flow Less CapEx to Interest Expense		 22.54 16.25 21.28 16.50 22.92 33.10 27.40 -7.68 10.91 8.83 23.37
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.79 0.73 0.76 0.81 0.86 0.88 0.63 0.86 0.89 0.98 1.04
Accounts Receivable Turnover		 5.74 4.95 4.97 5.02 5.23 5.28 4.13 5.95 5.49 5.48 5.43
Inventory Turnover		 1.93 1.78 1.99 1.84 1.66 1.62 1.28 1.80 1.60 1.45 1.41
Fixed Asset Turnover		 50.86 50.60 53.69 57.95 66.99 68.13 35.13 10.41 6.88 7.84 8.99
Accounts Payable Turnover		 4.11 3.68 3.89 4.21 4.47 4.76 4.65 5.49 4.60 5.15 5.57
Days Sales Outstanding (DSO)		 63.61 73.68 73.46 72.66 69.85 69.19 88.35 61.31 66.50 66.57 67.24
Days Inventory Outstanding (DIO)		 188.91 204.52 183.18 198.69 219.90 224.79 286.20 202.37 227.48 252.38 258.56
Days Payable Outstanding (DPO)		 88.90 99.15 93.92 86.69 81.63 76.68 78.58 66.50 79.27 70.85 65.51
Cash Conversion Cycle (CCC)		 163.61 179.05 162.73 184.66 208.12 217.30 295.98 197.18 214.71 248.10 260.28
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 222 319 307 360 379 389 452 597 737 871 894
Invested Capital Turnover		 2.17 1.73 1.66 1.77 1.83 1.86 1.28 1.68 1.67 1.64 1.65
Increase / (Decrease) in Invested Capital		 -15 97 -12 52 20 9.90 63 145 169 134 23
Enterprise Value (EV)		 601 626 883 1,211 1,916 2,170 1,807 3,428 2,958 4,500 4,205
Market Capitalization		 764 677 952 1,291 1,993 2,259 1,890 3,403 2,838 4,328 4,055
Book Value per Share		 $12.35 $11.79 $11.91 $13.89 $14.29 $14.87 $16.99 $18.02 $19.35 $21.87 $23.26
Tangible Book Value per Share		 $9.16 $5.30 $6.00 $7.46 $7.76 $8.45 $10.20 $11.28 $10.23 $12.60 $14.44
Total Capital		 499 575 558 631 632 632 749 916 993 1,054 1,129
Total Debt		 0.30 99 75 61 46 23 46 178 204 162 186
Total Long-Term Debt		 0.00 76 53 36 23 11 31 162 176 128 136
Net Debt		 -280 -161 -181 -218 -215 -230 -250 -142 -51 -21 -49
Capital Expenditures (CapEx)		 3.30 4.16 4.78 3.02 3.96 5.43 11 141 34 6.47 4.74
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 103 100 95 128 145 148 163 161 216 366 398
Debt-free Net Working Capital (DFNWC)		 383 360 351 407 406 401 459 481 472 548 632
Net Working Capital (NWC)		 383 338 330 382 382 389 445 465 443 514 582
Net Nonoperating Expense (NNE)		 -2.18 0.46 -0.26 0.39 -0.82 -0.30 0.53 -2.16 0.07 1.35 4.85
Net Nonoperating Obligations (NNO)		 -276 -157 -176 -211 -206 -220 -250 -142 -51 -21 -49
Total Depreciation and Amortization (D&A)		 10 9.08 15 12 11 8.73 9.07 13 28 23 35
Debt-free, Cash-free Net Working Capital to Revenue		 20.62% 21.35% 18.30% 21.70% 21.40% 20.75% 30.20% 18.32% 19.89% 27.74% 27.38%
Debt-free Net Working Capital to Revenue		 76.76% 76.80% 67.44% 68.76% 60.03% 56.22% 85.17% 54.66% 43.41% 41.61% 43.54%
Net Working Capital to Revenue		 76.70% 72.07% 63.31% 64.64% 56.61% 54.50% 82.47% 52.85% 40.78% 39.03% 40.10%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.95 $0.98 $1.07 $1.33 $1.72 $1.92 $1.21 $2.76 $3.80 $4.77 $5.13
Adjusted Weighted Average Basic Shares Outstanding		 30.93M 31.00M 31.07M 31.17M 31.31M 31.45M 31.54M 31.68M 31.86M 31.99M 32.04M
Adjusted Diluted Earnings per Share		 $0.95 $0.98 $1.07 $1.33 $1.71 $1.90 $1.21 $2.75 $3.78 $4.75 $5.12
Adjusted Weighted Average Diluted Shares Outstanding		 31.06M 31.10M 31.18M 31.31M 31.52M 31.69M 31.65M 31.84M 31.99M 32.14M 32.12M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 31M 31.10M 31.20M 31.30M 31.30M 0.00 31.64M 31.84M 32.11M 32.02M 32.12M
Normalized Net Operating Profit after Tax (NOPAT)		 35 39 47 57 69 76 50 110 157 189 211
Normalized NOPAT Margin		 7.04% 8.41% 8.95% 9.67% 10.20% 10.62% 9.37% 12.46% 14.46% 14.35% 14.55%
Pre Tax Income Margin		 11.36% 12.91% 12.87% 13.20% 14.19% 14.74% 12.87% 17.17% 17.87% 18.94% 18.48%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 36.74 21.35 28.24 38.69 36.65 48.28 34.75 53.25 53.44 22.23 35.02
NOPAT to Interest Expense		 23.79 13.95 18.37 27.94 26.72 35.31 25.63 38.18 41.98 16.81 26.62
EBIT Less CapEx to Interest Expense		 34.51 19.88 26.20 37.17 35.11 45.75 29.16 3.25 44.06 21.65 34.41
NOPAT Less CapEx to Interest Expense		 21.56 12.48 16.33 26.42 25.19 32.78 20.04 -11.83 32.61 16.23 26.01
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 52.24% 50.40% 52.90% 49.28% 51.35% 66.15% 42.29% 37.74% 55.75% 53.99% 59.36%
Augmented Payout Ratio		 52.48% 50.49% 53.08% 49.28% 51.35% 66.15% 42.29% 37.74% 55.75% 62.18% 59.36%

Quarterly Metrics And Ratios for Interparfums

This table displays calculated financial ratios and metrics derived from Interparfums' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 31,975,670.00 63,961,610.00 63,961,610.00 32,023,640.00 32,024,280.00 32,030,280.00 32,123,940.00 32,124,000.00 32,117,600.00 32,064,728.00 32,025,781.00
DEI Adjusted Shares Outstanding		 31,975,670.00 63,961,610.00 63,961,610.00 32,023,640.00 32,024,280.00 32,030,280.00 32,123,940.00 32,124,000.00 32,117,600.00 32,064,728.00 32,025,781.00
DEI Earnings Per Adjusted Shares Outstanding		 1.66 0.16 0.64 1.15 1.94 0.76 1.32 1.00 2.05 1.35 0.95
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 31.20% 5.78% 3.93% 10.67% 15.40% 9.97% 4.59% -2.42% 1.17% 1.79% 2.13%
EBITDA Growth		 35.85% -29.89% -18.50% 19.60% 19.47% 126.38% 7.47% -7.47% 3.95% -0.39% -15.28%
EBIT Growth		 37.73% -10.93% -23.14% 15.23% 16.70% 127.23% 8.04% -10.00% 4.56% -0.07% -15.26%
NOPAT Growth		 28.86% -44.26% -25.20% 16.95% 21.84% 151.58% 9.55% -8.67% 3.62% -1.35% -16.94%
Net Income Growth		 24.06% -51.39% -24.83% 9.60% 16.21% 224.39% 3.94% -11.59% 8.39% 2.35% -10.47%
EPS Growth		 27.69% -38.46% -24.40% 4.59% 16.27% 143.75% 3.94% -13.16% 6.22% 2.27% -4.04%
Operating Cash Flow Growth		 -13.87% 0.36% -606.17% 80.56% 334.76% 69.29% 85.84% -53.46% -16.12% 101.16% 284.07%
Free Cash Flow Firm Growth		 -48.95% 17.81% 14.13% -13.00% 15.36% 102.83% 128.29% 35.37% 98.23% -44.32% 276.72%
Invested Capital Growth		 24.34% 18.23% 19.30% 20.33% 19.42% 2.61% 2.65% 12.23% 8.25% 3.84% -8.86%
Revenue Q/Q Growth		 18.99% -10.66% -1.45% 5.64% 24.08% -14.87% -6.28% -1.44% 28.64% 0.00% -1.12%
EBITDA Q/Q Growth		 53.87% -76.85% 257.01% -5.96% 53.70% -56.13% 69.49% -19.04% 72.67% 0.00% -31.14%
EBIT Q/Q Growth		 57.69% -80.86% 308.93% -6.64% 59.70% -62.73% 94.43% -22.23% 85.54% 0.00% -34.05%
NOPAT Q/Q Growth		 57.86% -84.35% 396.59% -4.64% 64.46% -67.70% 116.24% -20.51% 86.60% 0.00% -33.06%
Net Income Q/Q Growth		 55.51% -87.55% 547.67% -12.58% 64.89% -65.25% 107.53% -25.64% 102.15% 0.00% -34.96%
EPS Q/Q Growth		 52.29% -80.72% 296.88% -10.24% 69.30% -59.59% 69.23% -25.00% 107.07% 0.00% -29.63%
Operating Cash Flow Q/Q Growth		 24.00% 365.35% -163.76% 149.08% 198.58% 81.19% -105.33% 261.29% 438.11% 0.00% 53,525.88%
Free Cash Flow Firm Q/Q Growth		 2.54% -19.74% 12.91% -11.18% 27.00% 104.00% 771.83% -353.98% 98.00% 0.00% 706.14%
Invested Capital Q/Q Growth		 4.30% 0.31% 13.28% 1.53% 3.52% -13.81% 13.33% 11.01% -0.16% 0.00% -2.57%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 63.87% 64.70% 62.47% 64.51% 63.86% 64.46% 63.74% 66.21% 63.51% 65.13% 65.54%
EBITDA Margin		 25.10% 6.50% 23.57% 20.98% 25.99% 13.39% 24.22% 19.89% 26.70% 23.70% 16.50%
Operating Margin		 23.70% 5.74% 20.98% 18.94% 24.96% 9.96% 22.16% 17.72% 25.27% 21.50% 14.35%
EBIT Margin		 23.90% 5.12% 21.25% 18.78% 24.17% 10.58% 21.95% 17.32% 24.98% 21.55% 14.37%
Profit (Net Income) Margin		 17.97% 2.50% 16.45% 13.62% 18.09% 7.39% 16.35% 12.34% 19.39% 16.44% 10.81%
Tax Burden Percent		 76.34% 55.16% 76.09% 76.08% 76.52% 72.78% 75.47% 76.11% 77.42% 75.40% 76.45%
Interest Burden Percent		 98.48% 88.62% 101.76% 95.31% 97.83% 95.89% 98.70% 93.58% 100.23% 101.19% 98.44%
Effective Tax Rate		 23.66% 44.84% 23.91% 23.92% 23.48% 27.22% 24.53% 23.89% 22.58% 24.60% 23.55%
Return on Invested Capital (ROIC)		 30.01% 5.19% 23.40% 21.41% 28.45% 11.93% 24.53% 18.50% 26.52% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 32.26% 11.26% 28.97% 15.13% 8.98% 10.50% 21.57% 13.95% 24.33% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -0.80% -0.48% 0.94% 0.75% 0.21% -0.40% 0.95% 1.20% 0.82% 0.00% 0.00%
Return on Equity (ROE)		 29.21% 4.71% 24.34% 22.16% 28.67% 11.53% 25.49% 19.71% 27.34% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 3.37% 6.81% 1.33% 1.03% 2.58% 21.03% 18.71% 8.12% 11.70% -3.77% 9.27%
Operating Return on Assets (OROA)		 24.80% 5.04% 20.71% 18.85% 23.87% 11.05% 23.09% 17.27% 24.02% 0.00% 0.00%
Return on Assets (ROA)		 18.64% 2.46% 16.03% 13.67% 17.87% 7.71% 17.20% 12.30% 18.64% 0.00% 0.00%
Return on Common Equity (ROCE)		 22.99% 3.69% 18.93% 17.56% 22.61% 9.07% 19.92% 15.67% 21.58% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 67 10 52 49 81 26 57 45 84 56 37
NOPAT Margin		 18.09% 3.17% 15.96% 14.41% 19.10% 7.25% 16.72% 13.49% 19.57% 16.21% 10.97%
Net Nonoperating Expense Percent (NNEP)		 -2.26% -6.07% -5.56% 6.28% 19.47% 1.42% 2.97% 4.56% 2.18% 2.95% 46.85%
Return On Investment Capital (ROIC_SIMPLE)		 6.33% 0.99% 4.77% 4.57% 6.79% 2.32% 4.78% 3.39% 6.41% 4.34% 3.03%
Cost of Revenue to Revenue		 36.13% 35.30% 37.53% 35.49% 36.14% 35.54% 36.26% 33.79% 36.49% 34.87% 34.46%
SG&A Expenses to Revenue		 40.17% 58.96% 41.49% 45.56% 38.90% 53.40% 41.59% 48.49% 38.24% 43.64% 51.19%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 40.17% 58.96% 41.49% 45.56% 38.90% 54.51% 41.59% 48.49% 38.24% 43.64% 51.19%
Earnings before Interest and Taxes (EBIT)		 88 17 69 64 103 38 74 58 107 74 49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 92 21 76 72 110 48 82 66 115 82 56
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.82 6.19 6.00 4.93 5.10 5.44 4.49 4.90 3.56 3.30 4.12
Price to Tangible Book Value (P/TBV)		 9.96 10.74 10.11 8.13 8.14 8.77 7.44 8.12 5.72 5.16 6.41
Price to Revenue (P/Rev)		 3.09 3.28 3.19 2.59 2.80 2.79 2.42 2.82 2.12 0.00 0.00
Price to Earnings (P/E)		 25.30 28.35 30.41 24.98 26.37 24.67 21.38 25.54 18.86 0.00 0.00
Dividend Yield		 1.89% 1.85% 1.98% 2.49% 2.32% 2.37% 2.76% 2.42% 3.26% 3.52% 2.86%
Earnings Yield		 3.95% 3.53% 3.29% 4.00% 3.79% 4.05% 4.68% 3.92% 5.30% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 4.83 5.17 4.58 3.81 4.08 4.70 3.72 3.91 2.99 2.93 3.65
Enterprise Value to Revenue (EV/Rev)		 3.23 3.42 3.40 2.80 2.98 2.90 2.57 3.01 2.29 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 15.18 16.49 18.20 14.75 15.36 13.62 11.99 14.23 10.71 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 16.64 17.99 19.73 16.06 16.74 15.35 13.48 16.10 12.08 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 21.36 23.80 26.36 21.37 21.88 20.19 17.68 21.04 15.83 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 39.79 42.55 73.98 52.65 32.24 22.41 16.23 20.11 16.26 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 158.84 82.14 375.89 403.41 172.27 22.66 20.15 50.92 26.55 0.00 37.51
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.20 0.18 0.19 0.20 0.21 0.20 0.18 0.26 0.19 0.16 0.13
Long-Term Debt to Equity		 0.15 0.14 0.15 0.14 0.16 0.14 0.13 0.16 0.13 0.11 0.09
Financial Leverage		 -0.02 -0.04 0.03 0.05 0.02 -0.04 0.04 0.09 0.03 -0.03 0.00
Leverage Ratio		 1.56 1.59 1.55 1.55 1.54 1.52 1.46 1.49 1.46 1.41 1.42
Compound Leverage Factor		 1.54 1.41 1.58 1.48 1.51 1.45 1.44 1.40 1.46 1.42 1.40
Debt to Total Capital		 16.66% 15.36% 16.25% 16.46% 17.53% 16.49% 14.98% 20.55% 15.74% 13.70% 11.78%
Short-Term Debt to Total Capital		 4.40% 3.23% 3.45% 4.38% 4.48% 4.42% 4.30% 7.62% 5.06% 4.25% 3.98%
Long-Term Debt to Total Capital		 12.26% 12.13% 12.81% 12.08% 13.05% 12.07% 10.68% 12.93% 10.68% 9.45% 7.81%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 17.73% 18.29% 18.43% 17.07% 17.30% 17.52% 18.47% 16.35% 17.82% 17.91% 17.81%
Common Equity to Total Capital		 65.61% 66.35% 65.32% 66.47% 65.17% 65.99% 66.55% 63.11% 66.44% 68.39% 70.40%
Debt to EBITDA		 0.63 0.59 0.71 0.69 0.76 0.60 0.56 0.88 0.66 0.00 0.00
Net Debt to EBITDA		 -0.03 -0.08 0.32 0.39 0.19 -0.16 0.02 0.22 0.06 0.00 0.00
Long-Term Debt to EBITDA		 0.47 0.47 0.56 0.50 0.57 0.44 0.40 0.56 0.45 0.00 0.00
Debt to NOPAT		 0.89 0.86 1.03 0.99 1.08 0.89 0.83 1.31 0.97 0.00 0.00
Net Debt to NOPAT		 -0.04 -0.11 0.46 0.56 0.27 -0.23 0.03 0.33 0.09 0.00 0.00
Long-Term Debt to NOPAT		 0.66 0.68 0.81 0.73 0.81 0.65 0.59 0.82 0.66 0.00 0.00
Altman Z-Score		 6.95 7.61 8.14 6.94 7.22 7.56 7.36 7.15 6.47 5.53 6.81
Noncontrolling Interest Sharing Ratio		 21.28% 21.67% 22.25% 20.76% 21.12% 21.29% 21.86% 20.51% 21.07% 21.22% 20.38%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.41 2.58 2.75 2.58 2.82 2.75 2.97 2.96 3.27 3.26 3.31
Quick Ratio		 1.34 1.35 1.31 1.15 1.52 1.55 1.57 1.53 1.86 1.88 1.82
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -103 -124 -108 -120 -88 3.50 31 -78 -1.55 17 137
Operating Cash Flow to CapEx		 1,276.46% 4,309.68% -4,906.52% 2,398.97% 9,926.99% 7,453.32% -510.97% 78.13% 1,024.27% 6.24% 4,442.69%
Free Cash Flow to Firm to Interest Expense		 -43.17 -29.34 -59.72 -61.82 -44.28 1.67 19.76 -43.39 -0.67 11.85 94.06
Operating Cash Flow to Interest Expense		 7.31 19.30 -28.75 13.14 38.49 65.73 -4.76 6.64 27.71 0.06 31.28
Operating Cash Flow Less CapEx to Interest Expense		 6.73 18.85 -29.34 12.59 38.11 64.85 -5.69 -1.86 25.00 -0.89 30.58
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.04 0.98 0.97 1.00 0.99 1.04 1.05 1.00 0.96 0.00 0.00
Accounts Receivable Turnover		 4.91 5.48 4.68 4.91 4.30 5.43 4.83 4.79 3.99 0.00 0.00
Inventory Turnover		 1.46 1.45 1.36 1.24 1.32 1.41 1.32 1.21 1.30 0.00 0.00
Fixed Asset Turnover		 8.22 7.84 7.98 8.28 8.62 8.99 9.08 8.42 8.30 0.00 0.00
Accounts Payable Turnover		 5.62 5.15 4.93 4.93 5.58 5.57 5.13 5.13 6.37 0.00 0.00
Days Sales Outstanding (DSO)		 74.40 66.57 78.00 74.41 84.96 67.24 75.55 76.13 91.40 0.00 0.00
Days Inventory Outstanding (DIO)		 249.69 252.38 268.85 294.40 276.67 258.56 276.08 302.88 280.65 0.00 0.00
Days Payable Outstanding (DPO)		 65.00 70.85 74.01 74.01 65.42 65.51 71.13 71.10 57.30 0.00 0.00
Cash Conversion Cycle (CCC)		 259.09 248.10 272.84 294.80 296.21 260.28 280.50 307.92 314.75 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 869 871 987 1,002 1,037 894 1,013 1,125 1,123 1,052 1,025
Invested Capital Turnover		 1.66 1.64 1.47 1.49 1.49 1.65 1.47 1.37 1.36 0.00 0.00
Increase / (Decrease) in Invested Capital		 170 134 160 169 169 23 26 123 86 39 -100
Enterprise Value (EV)		 4,197 4,500 4,525 3,820 4,229 4,205 3,769 4,396 3,354 3,083 3,737
Market Capitalization		 4,019 4,328 4,246 3,535 3,970 4,055 3,544 4,111 3,102 2,913 3,582
Book Value per Share		 $21.59 $21.87 $22.10 $22.39 $24.31 $23.26 $24.55 $26.13 $27.12 $27.53 $27.18
Tangible Book Value per Share		 $12.62 $12.60 $13.11 $13.57 $15.23 $14.44 $14.83 $15.75 $16.90 $17.63 $17.44
Total Capital		 1,052 1,054 1,084 1,079 1,195 1,129 1,185 1,330 1,311 1,289 1,236
Total Debt		 175 162 176 178 209 186 178 273 206 177 146
Total Long-Term Debt		 129 128 139 130 156 136 127 172 140 122 97
Net Debt		 -8.26 -21 79 101 52 -49 5.62 68 18 -61 -66
Capital Expenditures (CapEx)		 1.37 1.89 1.06 1.06 0.77 1.85 1.44 15 6.24 1.36 1.03
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 377 366 471 495 513 398 484 550 566 510 501
Debt-free Net Working Capital (DFNWC)		 560 548 568 572 670 632 656 755 754 747 713
Net Working Capital (NWC)		 514 514 530 525 617 582 605 654 688 692 664
Net Nonoperating Expense (NNE)		 0.45 2.19 -1.58 2.72 4.28 -0.49 1.26 3.84 0.77 -0.81 0.53
Net Nonoperating Obligations (NNO)		 -8.26 -21 79 101 52 -49 5.62 68 18 -61 -66
Total Depreciation and Amortization (D&A)		 4.41 4.55 7.50 7.52 7.71 10 7.67 8.59 7.39 7.41 7.27
Debt-free, Cash-free Net Working Capital to Revenue		 28.97% 27.74% 35.38% 36.35% 36.15% 27.38% 32.97% 37.69% 38.69% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 43.09% 41.61% 42.68% 41.98% 47.22% 43.54% 44.69% 51.77% 51.53% 0.00% 0.00%
Net Working Capital to Revenue		 39.53% 39.03% 39.87% 38.52% 43.45% 40.10% 41.21% 44.83% 47.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.33 $1.28 $1.15 $1.94 $0.76 $1.32 $1.00 $2.05 $1.35 $0.95
Adjusted Weighted Average Basic Shares Outstanding		 0.00 31.99M 32.04M 32.02M 32.03M 32.04M 32.12M 32.11M 32.11M 32.03M 32.03M
Adjusted Diluted Earnings per Share		 $0.00 $0.32 $1.27 $1.14 $1.93 $0.78 $1.32 $0.99 $2.05 $1.35 $0.95
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 32.14M 32.27M 32.27M 32.27M 32.12M 32.17M 32.15M 32.15M 32.03M 32.03M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 32.02M 32.02M 32.02M 32.03M 32.12M 32.12M 32.12M 32.06M 32.03M 32.03M
Normalized Net Operating Profit after Tax (NOPAT)		 67 10 52 49 81 26 57 45 84 56 37
Normalized NOPAT Margin		 18.09% 3.17% 15.96% 14.41% 19.10% 7.25% 16.72% 13.49% 19.57% 16.21% 10.97%
Pre Tax Income Margin		 23.54% 4.54% 21.62% 17.90% 23.65% 10.15% 21.67% 16.21% 25.04% 21.81% 14.15%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 36.69 3.99 38.10 33.11 51.89 18.22 48.14 32.37 46.56 51.83 33.64
NOPAT to Interest Expense		 27.77 2.47 28.62 25.41 41.01 12.48 36.67 25.21 36.46 38.98 25.68
EBIT Less CapEx to Interest Expense		 36.12 3.54 37.51 32.56 51.50 17.34 47.21 23.87 43.85 50.88 32.94
NOPAT Less CapEx to Interest Expense		 27.20 2.02 28.04 24.86 40.62 11.60 35.74 16.70 33.76 38.03 24.97
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 49.02% 53.99% 61.65% 64.69% 63.65% 59.36% 59.71% 63.84% 62.17% 0.00% 0.00%
Augmented Payout Ratio		 54.77% 62.18% 61.65% 67.04% 65.87% 59.36% 59.71% 64.86% 65.79% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Interparfums’ latest results show modest revenue growth, stronger liquidity and improved operating cash flow, but profitability softened in the second quarter of 2026. Revenue was $341.0 million, up 2.1% from $333.9 million in Q2 2025. However, operating income declined to $48.9 million from $59.2 million, while net income attributable to common shareholders fell to $30.5 million from $32.0 million. Diluted EPS decreased to $0.95 from $0.99.

The margin trend was mixed. The gross margin was approximately 65.5% in Q2 2026, compared with 66.2% a year earlier. The operating margin fell to roughly 14.3% from 17.7%, as selling, general and administrative expense increased 7.8% and consumed a larger share of gross profit. This follows a stronger Q1, when operating income was $74.1 million and diluted EPS was $1.35.

  • Improved liquidity: Cash and short-term investments totaled $211.3 million at June 30, 2026, up from $205.4 million a year earlier. Total current assets remained approximately $951.0 million, compared with $987.0 million in Q2 2025, while current liabilities declined to $287.3 million from $333.0 million.
  • Lower debt burden: Reported short- and long-term debt totaled approximately $145.7 million in Q2 2026, down substantially from roughly $254.4 million in Q2 2025 before considering the prior-period capital lease obligation. This helped improve the company’s balance-sheet flexibility.
  • Operating cash flow recovered: Cash flow from operations rose to $45.6 million in Q2 2026 from $11.9 million in Q2 2025. Q1 2026 operating cash flow was nearly breakeven at $0.1 million, compared with a $7.4 million outflow in Q1 2025.
  • Strong equity base: Total common equity was $870.5 million at the end of Q2 2026, up from $839.4 million a year earlier. Retained earnings increased to $838.6 million, supporting financial stability and future shareholder distributions.
  • Dividend increased: Cash dividends per common share were reported at $0.80 in 2026, compared with $0.75 in 2024 and $0.625 in 2023. The higher dividend supports the company’s income appeal, although it also represents a sizable use of cash.
  • Revenue growth has moderated: Quarterly revenue increased from $280.5 million in Q3 2022 to $341.0 million in Q2 2026, but recent growth has been relatively limited. Q2 2026 revenue rose only 2.1% year over year, following a 1.8% increase in Q1.
  • Cash generation remains volatile: The company has frequently experienced large swings in working capital and investment activity. In Q2 2026, $128.1 million of investment sales and maturities drove investing cash flow to a $115.0 million inflow, meaning the quarter’s $89.8 million increase in cash was not solely generated by operations.
  • Operating profitability weakened: Q2 2026 operating income declined 17.4% year over year, and the operating margin contracted by more than three percentage points. Sustained SG&A growth above revenue growth could pressure earnings if sales growth does not accelerate.
  • Common-shareholder earnings declined: Despite modest revenue growth, Q2 net income attributable to common shareholders fell 4.7% year over year. In addition, noncontrolling interests absorbed $6.4 million of consolidated net income, reducing the amount available to Interparfums’ common shareholders.
  • Inventory remains substantial: Inventory totaled $375.6 million at June 30, 2026, representing nearly 40% of current assets. Although inventory declined from $425.3 million a year earlier, elevated inventory levels could tie up working capital or require promotional activity if demand weakens.

Overall, Interparfums enters the second half of 2026 with a healthier balance sheet than a year earlier and better recent operating cash flow. The main issue for investors is whether the company can convert modest sales growth into stronger operating income. Monitoring SG&A discipline, inventory turnover and recurring operating cash flow will be important in determining whether the recent earnings slowdown is temporary or becomes a longer-term trend.

08/18/26 05:14 AM ETAI Generated. May Contain Errors.

Interparfums Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Interparfums' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

Interparfums' net income appears to be on an upward trend, with a most recent value of $203.43 million in 2024, rising from $37.35 million in 2014. The previous period was $187.78 million in 2023. See where experts think Interparfums is headed by visiting Interparfums' forecast page.

Interparfums' total operating income in 2024 was $274.80 million, based on the following breakdown:
  • Total Gross Profit: $927.34 million
  • Total Operating Expenses: $652.55 million

Over the last 10 years, Interparfums' total revenue changed from $499.26 million in 2014 to $1.45 billion in 2024, a change of 190.9%.

Interparfums' total liabilities were at $481.22 million at the end of 2025, a 2.7% increase from 2024, and a 127.8% increase since 2015.

In the past 10 years, Interparfums' cash and equivalents has ranged from $88.46 million in 2023 to $208.34 million in 2017, and is currently $158.09 million as of their latest financial filing in 2025.

Over the last 10 years, Interparfums' book value per share changed from 12.35 in 2014 to 23.26 in 2024, a change of 88.3%.


Related Companies

Financial statements for NASDAQ:IPAR last updated on 8/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War: What Happened at 1:11 P.M. Outside D.C.?
A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...
Banyan Hill Publishing | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
A Wall Street veteran shares two simple trading rules
A self-described Market Wizard says two simple rules, refined over decades on Wall Street, form the basis of h...
Brownstone Research | Sponsoredtc pixel
19 Factories. One AI Brain. One Hidden Stock.
A little-known aerospace manufacturer has linked 19 factories worldwide into a single AI-ready data system, dr...
The Oxford Club | Sponsoredtc pixel
Someone just dumped the biggest gold fund.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel